Skin Diseases, Vascular Products

Skin Diseases, Vascular	Welcome, Profile Billing Logout


Phase N/A 1 2 3 4 Trials	0	2468101214161820



Xolair (omalizumab) / Roche, Novartis




Berinert (C1 esterase inhibitor (human) IV) / CSL Behring




Remicade (infliximab) / J&J




gevokizumab (VPM087) / Novartis




Actemra IV (tocilizumab) / Roche, JW Pharma




Ruconest (conestat alfa) / SOBI, Pharming Group




Firazyr (icatibant) / Takeda




Humira (adalimumab) / AbbVie




avoralstat (BCX4161) / BioCryst




levocetirizine / Generic mfg.




Orencia (abatacept) / BMS




Enbrel (etanercept) / Pfizer, Amgen




Ilaris (canakinumab) / Novartis




Rituxan (rituximab) / Roche




azathioprine / Generic mfg.




prednisone / Generic mfg.




AZD1981 / AstraZeneca




Alesion (epinastine) / Boehringer Ingelheim




Arcalyst (rilonacept) / Regeneron, Kiniksa




Clairyg (intravenous normal human immunoglobulin) / LFB SA




Cosentyx (secukinumab) / Novartis




Gammagard Liquid (human normal immunoglobulin 10%) / Takeda




Gamunex (intravenous normal human immunoglobulin 10%) / Bayer, Grifols, Kedrion




Januvia (sitagliptin) / Merck (MSD)




Kineret (anakinra) / SOBI




Veldona (Interferon α lozenge) / Hayashibara, Otsuka, Amarillo




Zinbryta (daclizumab) / Biogen, AbbVie




carvedilol / Generic mfg.




cetirizine oral / Generic mfg.




ebastine / Generic mfg.




fexofenadine / Generic mfg.




hydroxyzine hydrochloride / Generic mfg.




mycophenolate mofetil / Generic mfg.




pravastatin / Generic mfg.




prednisone delayed-release tablet / Generic mfg.




quilizumab (MEMP1972A) / Roche



	Diseases Companies Products Productz Mechanisms of Action Sites